mochi compounded tirzepatide Sale Your GLP-1 Compound Access Could

not a maintenance dose) Weeks 58: 5 mg once weekly Then: consider +2.5 mg increments (e.g., 7.5 10 12.5 15 mg) no sooner than every 4 weeks, if appropriate and tolerated Maintenance target: 5 mg, 10 mg, or 15 mg once weekly, chosen by your clinician based on response and side effects This gradual approach is designed to reduce the risk of gastrointestinal (GI) side effects during dose changes and allow time to evaluate how youre doing at each step

Tirzepatide is a medication that targets both GLP-1 and GIP hormone receptors, creating a dual-action approach to appetite and metabolic regulation

It covers dose adjustments as you titrate through the standard schedule

Contact your doctor if symptoms persist

Some patients report feeling tired or weak during the initial treatment phase

Take a needle head and pull off the paper tab at the back